433 related articles for article (PubMed ID: 22498821)
1. Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma.
Singhi AD; Jain D; Kakar S; Wu TT; Yeh MM; Torbenson M
Am J Surg Pathol; 2012 May; 36(5):710-5. PubMed ID: 22498821
[TBL] [Abstract][Full Text] [Related]
2. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
de Boer WB; Segal A; Frost FA; Sterrett GF
Cancer; 2000 Oct; 90(5):273-8. PubMed ID: 11038423
[TBL] [Abstract][Full Text] [Related]
3. A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
Swanson BJ; Yearsley MM; Marsh W; Frankel WL
Arch Pathol Lab Med; 2015 Apr; 139(4):537-42. PubMed ID: 25822763
[TBL] [Abstract][Full Text] [Related]
4. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
5. Liver pathology in obesity.
Suriawinata A; Fiel MI
Semin Liver Dis; 2004 Nov; 24(4):363-70. PubMed ID: 15605304
[TBL] [Abstract][Full Text] [Related]
6. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
Stefano JT; de Oliveira CP; Corrêa-Giannella ML; Soares IC; Kubrusly MS; Bellodi-Privato M; de Mello ES; de Lima VM; Carrilho FJ; Alves VA
Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of the reticulin stain in the differential diagnosis of liver nodules on fine-needle aspiration biopsy cell block preparations.
Bergman S; Graeme-Cook F; Pitman MB
Mod Pathol; 1997 Dec; 10(12):1258-64. PubMed ID: 9436973
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients.
Valva P; De Matteo E; Galoppo M; Pedreira A; Giacove G; Lezama C; Marco I; Galoppo MC; Preciado MV
Hum Pathol; 2008 Dec; 39(12):1816-22. PubMed ID: 18715620
[TBL] [Abstract][Full Text] [Related]
10. Hepatic adenoma and focal nodular hyperplasia.
Shortell CK; Schwartz SI
Surg Gynecol Obstet; 1991 Nov; 173(5):426-31. PubMed ID: 1658955
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence and risk factors of hepatic steatosis in patients with chronic hepatitis B].
Shi JP; Fan JG; Wu R; Gao XQ; Zhang L; Wang H
Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):519-23. PubMed ID: 18647531
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic criteria for non-alcoholic steatohepatitis].
Hashimoto E
Nihon Rinsho; 2006 Jun; 64(6):1025-32. PubMed ID: 16768105
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.
Ahmad I; Iyer A; Marginean CE; Yeh MM; Ferrell L; Qin L; Bifulco CB; Jain D
Hum Pathol; 2009 May; 40(5):726-34. PubMed ID: 19157505
[TBL] [Abstract][Full Text] [Related]
14. Biopsies of hepatocellular carcinoma with no reticulin loss: an important diagnostic pitfall.
Yasir S; Chen ZE; Said S; Wu TT; Torbenson M
Hum Pathol; 2021 Jan; 107():20-28. PubMed ID: 33039370
[TBL] [Abstract][Full Text] [Related]
15. Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis.
Cortez-Pinto H; Baptista A; Camilo ME; de Moura MC
Hepatogastroenterology; 2001; 48(37):87-90. PubMed ID: 11269008
[TBL] [Abstract][Full Text] [Related]
16. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
Lackner C
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):223-31. PubMed ID: 21476917
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
20. The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis.
Salomao M; Remotti H; Vaughan R; Siegel AB; Lefkowitch JH; Moreira RK
Hum Pathol; 2012 May; 43(5):737-46. PubMed ID: 22018903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
